Japan Biotech Home Base

 

                                                        Featured Company: Genaris, Inc.

Company Name

Genaris, Inc.

Company Address

Leading Venture Plaza 510, 75-1 Ono-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0046, Japan
TEL & FAX:+81-45-521-1523

Homepage Address

http://www.genaris.com/index.htm

Email Contact

info@genaris.co.jp

President

Tatsunari Nishi 

Principal Area of Business

Genaris is a new-generation bio-analysis company that has developed new technologies for predicting genes (CDSs, rRNA genes, and tRNA genes), transcription units, selenocysteine codons, and gene expression levels. The company uses this technology to solve complex biological problems.

Principal Products/Business Activities

l         Development of Technology and Software for Genome Information Analyses-Genaris develops new technology for the identification of gene structures, the prediction of gene product functions, and the prediction of gene expression levels through collaborative research with universities. Then, we use our new technology to develop genome information analysis software

l        Creation of Microbial Genome Databases-Genaris creates microbial genome databases by using our proprietary software to add a variety of original annotations to published sequence information on microbial genomes.

l        Development of Technology for DNA Chip Data Analyses-Genaris develops technology and software that analyze DNA chip data using proprietary algorithms.

l        Contract Research for Genome Information-Genaris offers a contract research service which adds annotations to your genome sequences using our proprietary technology and software.

Business Goals

Genaris aims at developing the pioneering approaches to analyzing biological information based on the knowledge of biology and informatics cultivated to date. Our mission is to contribute to solving a variety of issues from health maintenance to environmental preservations through supporting your research and development.

Year of Establishment

January 18, 2002

 


|Japan Biotech| |Home Base|